Concepedia

Shengnan Luo

SL

Statistics

Publications

11

Citations

523

H-Index

10

Active since

2019

Affiliations

Third Affiliated Hospital of Harbin Medical University(Current)

Harbin Medical University

Second Affiliated Hospital of Harbin Medical University

Heilongjiang Academy of Sciences

Wenzhou Medical University

Shengnan Luo is an author at Third Affiliated Hospital of Harbin Medical University specializing in oncology, life sciences, and molecular oncology.

Publications per year

2019–2026

11

Publications

11

Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer

Chao Liu, Ruiqi Liu, Bojun Wang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 248 citations · Full text

, , +17

The MicroRNA MiR-29c Alleviates Renal Fibrosis via TPM1-Mediated Suppression of the Wnt/β-Catenin Pathway

Huiya Huang, Xiaozhong Huang, Shengnan Luo et al. · Frontiers in Physiology · 2020 · 55 citations · Full text

, , +15

A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer

Jianhua Nie, Dan Shan, Shun Li et al. · Frontiers in Oncology · 2021 · 51 citations · Full text

, , +17

STING agonist and IDO inhibitor combination therapy inhibits tumor progression in murine models of colorectal cancer

Jiaqi Shi, Caiqi Liu, Shengnan Luo et al. · Cellular Immunology · 2021 · 51 citations

, , +12

An alternatively spliced STING isoform localizes in the cytoplasmic membrane and directly senses extracellular cGAMP

Xiaobo Li, Yuanyuan Zhu, Xiao Zhang et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 2022 · 30 citations · Full text

, , +13

1–5 of 11